{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:01:21Z","timestamp":1787500881561,"version":"build-2736575974"},"reference-count":50,"publisher":"American Chemical Society (ACS)","issue":"23","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240051"],"award-info":[{"award-number":["BK20240051"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241043"],"award-info":[{"award-number":["BK20241043"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077110"],"award-info":[{"award-number":["22077110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107090"],"award-info":[{"award-number":["22107090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"XZHMU-QL Joint Research Fund","award":["QL-QN002"],"award-info":[{"award-number":["QL-QN002"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2025ZB139"],"award-info":[{"award-number":["2025ZB139"]}]},{"name":"Jiangsu Province Graduate Research and Practice Innovation Program","award":["KYCX25_3258"],"award-info":[{"award-number":["KYCX25_3258"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vasopressin V2 receptor (V2R) is a validated therapeutic target for autosomal dominant polycystic kidney disease (ADPKD). Most reported V2R antagonists share a benzoazacyclic scaffold with limited structural diversity. In this study, structural analysis of V2R bound to the FDA-approved V2R antagonist tolvaptan and a previously reported derivative (compound 18) revealed that the interaction with a hydrophobic subpocket formed by residues V2065.39, I2095.42, and F2876.51 plays a critical role in antagonistic activity. Guided by this structural insight, we designed a series of non-benzoazacyclic analogs. Compound 29 (XYDC2050) exhibited high V2R binding affinity (Ki = 2.8 \u00b1 0.1 nM) and potent cAMP inhibition (IC50 = 12.0 \u00b1 2.0 nM). Notably, XYDC2050 displayed 162-fold selectivity over V1AR, surpassing that of tolvaptan (123-fold). In vitro and in vivo studies demonstrated that XYDC2050 effectively suppressed renal cyst formation and slowed disease progression. These results support XYDC2050 as a potential lead compound for ADPKD therapy.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02474","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T14:19:55Z","timestamp":1764425995000},"page":"25438-25455","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of\nNon-benzoazacyclic V2R Antagonists\nfor the Treatment of Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2127-1841","authenticated-orcid":true,"given":"Haiyang","family":"Zhong","sequence":"first","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Chen","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchao","family":"Liu","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Fu","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yang","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Shi","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhan","family":"Sun","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-4825","authenticated-orcid":true,"given":"Dong","family":"Guo","sequence":"additional","affiliation":[{"name":"Xuzhou Medical University , , 209 Tongshan Road , , ,","place":["Xuzhou, Jiangsu, China, 221004"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"2026072715444990600_cit1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney\ndisease","volume":"393","author":"Gall","year":"2019","journal-title":"Lancet"},{"key":"2026072715444990600_cit2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2025.0310","article-title":"Autosomal\nDominant Polycystic Kidney Disease: A Review","volume":"333","author":"Chebib","year":"2025","journal-title":"JAMA"},{"key":"2026072715444990600_cit3","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1152\/physrev.00018.2024","article-title":"Physiologic mechanisms\nunderlying polycystic kidney\ndisease","volume":"105","author":"Boletta","year":"2025","journal-title":"Physiol. Rev."},{"key":"2026072715444990600_cit4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","article-title":"KDIGO 2025 clinical practice guideline\nfor the evaluation,\nmanagement, and treatment of autosomal dominant polycystic kidney\ndisease (ADPKD): executive summary","volume":"107","author":"Torres","year":"2025","journal-title":"Kidney Int."},{"key":"2026072715444990600_cit5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology\nof polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J. Cell Biol."},{"key":"2026072715444990600_cit6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat.\nRev. Dis. Primers"},{"key":"2026072715444990600_cit7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1517\/14728222.2015.1083979","article-title":"Therapeutic\ntargets for polycystic kidney disease","volume":"20","author":"Wilson","year":"2016","journal-title":"Expert\nOpin. Ther. Targets"},{"key":"2026072715444990600_cit8","doi-asserted-by":"publisher","first-page":"F931","DOI":"10.1152\/ajprenal.00604.2013","article-title":"The physiological\nand pathophysiological functions of renal and extrarenal vasopressin\nV2 receptors","volume":"306","author":"Juul","year":"2014","journal-title":"Am. J. Physiol. Renal.\nPhysiol."},{"key":"2026072715444990600_cit9","doi-asserted-by":"publisher","first-page":"981963","DOI":"10.3389\/fmolb.2022.981963","article-title":"Emerging therapies\nfor autosomal dominant polycystic\nkidney disease with a focus on cAMP signaling","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"2026072715444990600_cit10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal\ncystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"2026072715444990600_cit11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ndt\/gfy297","article-title":"Pro: Tolvaptan\ndelays the progression of autosomal dominant polycystic kidney disease","volume":"34","author":"Torres","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"2026072715444990600_cit12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.kint.2023.02.010","article-title":"Drug repurposing in autosomal dominant polycystic kidney\ndisease","volume":"103","author":"Zhou","year":"2023","journal-title":"Kidney Int."},{"key":"2026072715444990600_cit13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-019-1056-1","article-title":"Tolvaptan:\nA Review in Autosomal Dominant Polycystic Kidney Disease","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"2026072715444990600_cit14","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1021\/jm960133o","article-title":"Orally active, nonpeptide\nvasopressin V2 receptor antagonists: a novel series of\n1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and\nrelated compounds","volume":"39","author":"Ogawa","year":"1996","journal-title":"J. Med. Chem."},{"key":"2026072715444990600_cit15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/s0968-0896(99)00101-7","article-title":"7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl\n]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061) a potent, orally\nactive nonpeptide arginine vasopressin V2 receptor antagonist","volume":"7","author":"Kondo","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"2026072715444990600_cit16","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1021\/acs.jmedchem.3c00015","article-title":"Structure-Affinity and Structure-Kinetic\nRelationship Studies of Benzodiazepine Derivatives for the Development\nof Efficacious Vasopressin V2 Receptor Antagonists","volume":"66","author":"Cao","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026072715444990600_cit17","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1021\/acs.jmedchem.2c00567","article-title":"Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor\nAntagonists for the Treatment of Autosomal Dominant Kidney Disease","volume":"65","author":"Cao","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026072715444990600_cit18","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1021\/jm980179c","article-title":"5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1,\n4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985):\nan orally active arginine vasopressin antagonist with selectivity\nfor V2 receptors","volume":"41","author":"Albright","year":"1998","journal-title":"J. Med. Chem."},{"key":"2026072715444990600_cit19","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/S0960-894X(02)00649-2","article-title":"Bridged bicyclic vasopressin receptor\nantagonists with V2-selective or dual V1a\/V2 activity","volume":"12","author":"Dyatkin","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026072715444990600_cit20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/13543776.2023.2218546","article-title":"Vasopressin\nreceptor antagonists:\na patent summary (2018\u20132022)","volume":"33","author":"Baska","year":"2023","journal-title":"Expert\nOpin. Ther. Pat."},{"key":"2026072715444990600_cit21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/s0960-894x(02)01059-4","article-title":"Synthesis\nand biological evaluation of novel indoloazepine derivatives as non-peptide\nvasopressin V2 receptor antagonists","volume":"13","author":"Matthews","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026072715444990600_cit22","doi-asserted-by":"publisher","first-page":"173157","DOI":"10.1016\/j.ejphar.2020.173157","article-title":"Revisit ligand-receptor\ninteraction at the human vasopressin V2 receptor: A kinetic\nperspective","volume":"880","author":"Liu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"2026072715444990600_cit23","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1038\/s41467-025-59114-5","article-title":"Inactive structures\nof the vasopressin V2 receptor reveal distinct binding\nmodes for Tolvaptan and Mambaquaretin toxin","volume":"16","author":"Fouillen","year":"2025","journal-title":"Nat. Commun."},{"key":"2026072715444990600_cit24","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/s41401-024-01325-5","article-title":"Structural\nbasis of tolvaptan binding to the vasopressin V2 receptor","volume":"45","author":"Liu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"2026072715444990600_cit25","doi-asserted-by":"publisher","first-page":"9734","DOI":"10.1038\/s41467-025-64735-x","article-title":"Structural Insights into Antagonist Recognition by\nthe Vasopressin V2 Receptor","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat.\nCommun."},{"key":"2026072715444990600_cit26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.drudis.2011.11.007","article-title":"Bridging solubility\nbetween drug\ndiscovery and development","volume":"17","author":"Di","year":"2012","journal-title":"Drug Discovery Today"},{"key":"2026072715444990600_cit27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery\nstrategies: review of recent\nadvances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm.\nSin. B"},{"key":"2026072715444990600_cit28","unstructured":"Australian Public Assessment Report for Tolvaptan\n(Jinarc). Therapeutic\nGoods Administration; Otsuka Australia Pharmaceutical\nPty Ltd: Canberra, 2018."},{"key":"2026072715444990600_cit29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/B978-0-12-373870-7.00017-X","article-title":"Molecular Biology\nand Gene Regulation of Vasopressin","volume-title":"Textbook\nof Nephro-Endocrinology","author":"Tiwari","year":"2009"},{"key":"2026072715444990600_cit30","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between\nthe inhibition constant (K1) and the concentration\nof inhibitor which causes 50% inhibition (I50) of an enzymatic reaction","volume":"22","author":"Prusoff","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"2026072715444990600_cit31","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1021\/acs.jmedchem.2c00011","article-title":"Long Residence Time at the Vasopressin\nV2 Receptor Translates into Superior Inhibitory Effects\nin Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney\nDisease","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026072715444990600_cit32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bcp.2019.03.032","article-title":"Long residence\ntime adenosine A1 receptor agonists produce sustained wash-resistant\nantilipolytic effect in rat adipocytes","volume":"164","author":"Yun","year":"2019","journal-title":"Biochem.\nPharmacol."},{"key":"2026072715444990600_cit33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving\nthe speed and accuracy of\ndocking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"2026072715444990600_cit34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn a multifunctional\nwavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"2026072715444990600_cit35","doi-asserted-by":"publisher","first-page":"082503","DOI":"10.1063\/5.0216272","article-title":"A comprehensive\nelectron wavefunction analysis toolbox for chemists, Multiwfn","volume":"161","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."},{"key":"2026072715444990600_cit36","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","article-title":"High-resolution\ncomparative\nmodeling with RosettaCM","volume":"21","author":"Song","year":"2013","journal-title":"Structure"},{"key":"2026072715444990600_cit37","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database\nand PPM web server: resources for positioning of proteins in membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2026072715444990600_cit38","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical\nuser interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"2026072715444990600_cit39","doi-asserted-by":"publisher","first-page":"035103","DOI":"10.1063\/5.0012280","article-title":"CHARMM-GUI supports the Amber force fields","volume":"153","author":"Lee","year":"2020","journal-title":"J. Chem. Phys."},{"key":"2026072715444990600_cit40","doi-asserted-by":"publisher","first-page":"074501","DOI":"10.1063\/1.4960175","article-title":"Accuracy limit of\nrigid 3-point water models","volume":"145","author":"Izadi","year":"2016","journal-title":"J. Chem. Phys."},{"key":"2026072715444990600_cit41","unstructured":"Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. J. A.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.\n          Gaussian 09; Gaussian, Inc.: Wallingford, CT,\nUSA, 2009."},{"key":"2026072715444990600_cit42","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic\npotential based method using charge restraints for deriving atomic\ncharges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"2026072715444990600_cit43","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development\nand testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"2026072715444990600_cit44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: Amino-Acid-Specific Protein Backbone Parameters\nTrained against Quantum Mechanics Energy Surfaces in Solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"key":"2026072715444990600_cit45","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","article-title":"Lipid21:\nComplex Lipid Membrane Simulations\nwith AMBER","volume":"18","author":"Dickson","year":"2022","journal-title":"J. Chem. Theory Comput."},{"key":"2026072715444990600_cit46","unstructured":"Case, D. A.; Belfon, K.; Ben-Shalom, I. Y.; Brozell, S. R.; Cerutti, D. S.; Cheatham, T. E.; Cruzeiro, V. W. D.; Darden, T. A.; Duke, R. E.; Giambasu, G.; Gilson, M. K.; Gohlke, H.; Goetz, A. W.; Harris, R.; Izadi, S.; Izmailov, S. A.; Kasavajhala, K.; Kovalenko, A.; Krasny, R.; Kurtzman, T.; Lee, T. S.; LeGrand, S.; Li, P.; Lin, C.; Liu, J.; Luchko, T.; Luo, R.; Man, V.; Merz, K. M.; Miao, Y.; Mikhailovskii, O.; Monard, G.; Nguyen, H.; Onufriev, A.; Pan, F.; Pantano, S.; Qi, R.; Roe, D. R.; Roitberg, A.; Sagui, C.; Schott-Verdugo, S.; Shen, J.; Simmerling, C. L.; Skrynnikov, N. R.; Smith, J.; Swails, J.; Walker, R. C.; Wang, J.; Wilson, L.; Wolf, R. M.; Wu, X.; Xiong, Y.; Xue, Y.; York, D. M.; Kollman, P. A.\n          AMBER 2020; University of California: San Francisco, 2020."},{"key":"2026072715444990600_cit47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian\nequations of motion of a system with constraints: molecular dynamics\nof n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"2026072715444990600_cit48","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle\nmesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Comput. Phys."},{"key":"2026072715444990600_cit49","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for Processing and Analysis\nof Molecular Dynamics Trajectory Data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem.\nTheory Comput."},{"key":"2026072715444990600_cit50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance\nof the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free\nenergy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02474","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/23\/25438\/66288505\/acs.jmedchem.5c02474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/23\/25438\/66288505\/acs.jmedchem.5c02474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:57:47Z","timestamp":1785182267000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/23\/25438\/5234456\/Discovery-of-Non-benzoazacyclic-V2R-Antagonists"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":50,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,11,29]]},"published-print":{"date-parts":[[2025,12,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02474","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]}}}